Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181


LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer.

Li Q, Liu B, Chao HP, Ji Y, Lu Y, Mehmood R, Jeter C, Chen T, Moore JR, Li W, Liu C, Rycaj K, Tracz A, Kirk J, Calhoun-Davis T, Xiong J, Deng Q, Huang J, Foster BA, Gokhale A, Chen X, Tang DG.

Nat Commun. 2019 Dec 2;10(1):5494. doi: 10.1038/s41467-019-13532-4.


ATG5 cancer mutations and alternative mRNA splicing reveal a conjugation switch that regulates ATG12-ATG5-ATG16L1 complex assembly and autophagy.

Wible DJ, Chao HP, Tang DG, Bratton SB.

Cell Discov. 2019 Aug 27;5:42. doi: 10.1038/s41421-019-0110-1. eCollection 2019.


Tumor Dormancy and Slow-Cycling Cancer Cells.

Davis JE Jr, Kirk J, Ji Y, Tang DG.

Adv Exp Med Biol. 2019;1164:199-206. doi: 10.1007/978-3-030-22254-3_15. Review.


Systematic evaluation of RNA-Seq preparation protocol performance.

Chao HP, Chen Y, Takata Y, Tomida MW, Lin K, Kirk JS, Simper MS, Mikulec CD, Rundhaug JE, Fischer SM, Chen T, Tang DG, Lu Y, Shen J.

BMC Genomics. 2019 Jul 11;20(1):571. doi: 10.1186/s12864-019-5953-1.


USP22 controls multiple signaling pathways that are essential for vasculature formation in the mouse placenta.

Koutelou E, Wang L, Schibler AC, Chao HP, Kuang X, Lin K, Lu Y, Shen J, Jeter CR, Salinger A, Wilson M, Chen YC, Atanassov BS, Tang DG, Dent SYR.

Development. 2019 Feb 22;146(4). pii: dev174037. doi: 10.1242/dev.174037.


Prostate Luminal Progenitor Cells in Development and Cancer.

Zhang D, Zhao S, Li X, Kirk JS, Tang DG.

Trends Cancer. 2018 Nov;4(11):769-783. doi: 10.1016/j.trecan.2018.09.003. Epub 2018 Oct 1. Review.


Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses.

Li Q, Deng Q, Chao HP, Liu X, Lu Y, Lin K, Liu B, Tang GW, Zhang D, Tracz A, Jeter C, Rycaj K, Calhoun-Davis T, Huang J, Rubin MA, Beltran H, Shen J, Chatta G, Puzanov I, Mohler JL, Wang J, Zhao R, Kirk J, Chen X, Tang DG.

Nat Commun. 2018 Sep 6;9(1):3600. doi: 10.1038/s41467-018-06067-7.


"Splice" a way towards neuroendocrine prostate cancer.

Zhang D, Tang DG.

EBioMedicine. 2018 Sep;35:12-13. doi: 10.1016/j.ebiom.2018.08.037. Epub 2018 Aug 31. No abstract available.


Mitochondrial ROS-derived PTEN oxidation activates PI3K pathway for mTOR-induced myogenic autophagy.

Kim JH, Choi TG, Park S, Yun HR, Nguyen NNY, Jo YH, Jang M, Kim J, Kim J, Kang I, Ha J, Murphy MP, Tang DG, Kim SS.

Cell Death Differ. 2018 Nov;25(11):1921-1937. doi: 10.1038/s41418-018-0165-9. Epub 2018 Jul 24.


Cyclophilin B induces chemoresistance by degrading wild-type p53 via interaction with MDM2 in colorectal cancer.

Choi TG, Nguyen MN, Kim J, Jo YH, Jang M, Nguyen NNY, Yun HR, Choe W, Kang I, Ha J, Tang DG, Kim SS.

J Pathol. 2018 Sep;246(1):115-126. doi: 10.1002/path.5107. Epub 2018 Aug 6.


Concise Review: Prostate Cancer Stem Cells: Current Understanding.

Skvortsov S, Skvortsova II, Tang DG, Dubrovska A.

Stem Cells. 2018 Oct;36(10):1457-1474. doi: 10.1002/stem.2859. Epub 2018 Aug 27. Review.


FAM35A associates with REV7 and modulates DNA damage responses of normal and BRCA1-defective cells.

Tomida J, Takata KI, Bhetawal S, Person MD, Chao HP, Tang DG, Wood RD.

EMBO J. 2018 Jun 15;37(12). pii: e99543. doi: 10.15252/embj.201899543. Epub 2018 May 22.


Cancer stem cells: Regulation programs, immunological properties and immunotherapy.

Zhang D, Tang DG, Rycaj K.

Semin Cancer Biol. 2018 Oct;52(Pt 2):94-106. doi: 10.1016/j.semcancer.2018.05.001. Epub 2018 May 9. Review.


Internal Versus External Compression of a Left Ventricular Assist Device Outflow Graft: Diagnosis With Intravascular Ultrasound and Treatment With Stenting.

Trankle CR, Quader MA, Grizzard JD, Tang DG, Shah KB, Paris K, Shepard CK, Gertz ZM.

Circ Heart Fail. 2018 May;11(5):e004959. doi: 10.1161/CIRCHEARTFAILURE.118.004959. No abstract available.


Exercise Capacity in Patients with the Total Artificial Heart.

Canada JM, Evans RK, Abbate A, Arena R, Tang DG, Kasirajan V, Shah KB.

ASAIO J. 2019 Jan;65(1):36-42. doi: 10.1097/MAT.0000000000000746.


Histone 2B-GFP Label-Retaining Prostate Luminal Cells Possess Progenitor Cell Properties and Are Intrinsically Resistant to Castration.

Zhang D, Jeter C, Gong S, Tracz A, Lu Y, Shen J, Tang DG.

Stem Cell Reports. 2018 Jan 9;10(1):228-242. doi: 10.1016/j.stemcr.2017.11.016. Epub 2017 Dec 21.


Molecular determinants of prostate cancer metastasis.

Rycaj K, Tang DG.

Oncotarget. 2017 Sep 19;8(50):88211-88231. doi: 10.18632/oncotarget.21085. eCollection 2017 Oct 20. Review.


Transgenic overexpression of NanogP8 in the mouse prostate is insufficient to initiate tumorigenesis but weakly promotes tumor development in the Hi-Myc mouse model.

Liu B, Gong S, Li Q, Chen X, Moore J, Suraneni MV, Badeaux MD, Jeter CR, Shen J, Mehmood R, Fan Q, Tang DG.

Oncotarget. 2017 Apr 18;8(32):52746-52760. doi: 10.18632/oncotarget.17186. eCollection 2017 Aug 8.


Numb-/low Enriches a Castration-Resistant Prostate Cancer Cell Subpopulation Associated with Enhanced Notch and Hedgehog Signaling.

Guo Y, Zhang K, Cheng C, Ji Z, Wang X, Wang M, Chu M, Tang DG, Zhu HH, Gao WQ.

Clin Cancer Res. 2017 Nov 1;23(21):6744-6756. doi: 10.1158/1078-0432.CCR-17-0913. Epub 2017 Jul 27.


Surgical Treatment of Heart Failure.

Higgins RSD, Kilic A, Tang DG.

Surg Clin North Am. 2017 Aug;97(4):923-946. doi: 10.1016/j.suc.2017.04.003. Review.


Cellular determinants and microenvironmental regulation of prostate cancer metastasis.

Rycaj K, Li H, Zhou J, Chen X, Tang DG.

Semin Cancer Biol. 2017 Jun;44:83-97. doi: 10.1016/j.semcancer.2017.03.009. Epub 2017 Apr 11. Review.


Infections in Patients with a Total Artificial Heart Are Common but Rarely Fatal.

Hidalgo LF, Shah KB, Cooke RH, Tang DG, Kasirajan V, Cooper HA, Aronow WS.

ASAIO J. 2017 Nov/Dec;63(6):736-739. doi: 10.1097/MAT.0000000000000562.


Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors that Can Function as a Cell of Origin for Prostate Cancer.

Zhang D, Lin K, Lu Y, Rycaj K, Zhong Y, Chao HP, Calhoun-Davis T, Shen J, Tang DG.

Stem Cells Transl Med. 2017 Mar;6(3):748-760. doi: 10.5966/sctm.2016-0243. Epub 2016 Sep 29.


Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens.

Liu X, Krawczyk E, Suprynowicz FA, Palechor-Ceron N, Yuan H, Dakic A, Simic V, Zheng YL, Sripadhan P, Chen C, Lu J, Hou TW, Choudhury S, Kallakury B, Tang DG, Darling T, Thangapazham R, Timofeeva O, Dritschilo A, Randell SH, Albanese C, Agarwal S, Schlegel R.

Nat Protoc. 2017 Feb;12(2):439-451. doi: 10.1038/nprot.2016.174. Epub 2017 Jan 26.


MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes.

Liu C, Liu R, Zhang D, Deng Q, Liu B, Chao HP, Rycaj K, Takata Y, Lin K, Lu Y, Zhong Y, Krolewski J, Shen J, Tang DG.

Nat Commun. 2017 Jan 23;8:14270. doi: 10.1038/ncomms14270.


NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis.

Jeter CR, Liu B, Lu Y, Chao HP, Zhang D, Liu X, Chen X, Li Q, Rycaj K, Calhoun-Davis T, Yan L, Hu Q, Wang J, Shen J, Liu S, Tang DG.

Cell Discov. 2016 Nov 15;2:16041. eCollection 2016.


Impact of INTERMACS Profile on Clinical Outcomes for Patients Supported With the Total Artificial Heart.

Shah KB, Thanavaro KL, Tang DG, Quader MA, Mankad AK, Tchoukina I, Thacker LR, Smallfield MC, Katlaps G, Hess ML, Cooke RH, Kasirajan V.

J Card Fail. 2016 Nov;22(11):913-920. doi: 10.1016/j.cardfail.2016.04.016. Epub 2016 Apr 27.


miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.

Liu R, Liu C, Zhang D, Liu B, Chen X, Rycaj K, Jeter C, Calhoun-Davis T, Li Y, Yang T, Wang J, Tang DG.

Oncotarget. 2016 Aug 30;7(35):56628-56642. doi: 10.18632/oncotarget.10652.


Prospective Evaluation of Implantable Cardioverter-Defibrillator Lead Function During and After Left Ventricular Assist Device Implantation.

Hu YL, Kasirajan V, Tang DG, Shah KB, Koneru JN, Grizzard JD, Ellenbogen KA, Kron J.

JACC Clin Electrophysiol. 2016 Jun;2(3):343-354. doi: 10.1016/j.jacep.2016.01.008. Epub 2016 Mar 23.


Generation of a C57BL/6 MYC-Driven Mouse Model and Cell Line of Prostate Cancer.

Ellis L, Ku S, Li Q, Azabdaftari G, Seliski J, Olson B, Netherby CS, Tang DG, Abrams SI, Goodrich DW, Pili R.

Prostate. 2016 Sep;76(13):1192-202. doi: 10.1002/pros.23206. Epub 2016 May 26.


ATXN7L3 and ENY2 Coordinate Activity of Multiple H2B Deubiquitinases Important for Cellular Proliferation and Tumor Growth.

Atanassov BS, Mohan RD, Lan X, Kuang X, Lu Y, Lin K, McIvor E, Li W, Zhang Y, Florens L, Byrum SD, Mackintosh SG, Calhoun-Davis T, Koutelou E, Wang L, Tang DG, Tackett AJ, Washburn MP, Workman JL, Dent SY.

Mol Cell. 2016 May 19;62(4):558-71. doi: 10.1016/j.molcel.2016.03.030. Epub 2016 Apr 28.


Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer.

Chen X, Li Q, Liu X, Liu C, Liu R, Rycaj K, Zhang D, Liu B, Jeter C, Calhoun-Davis T, Lin K, Lu Y, Chao HP, Shen J, Tang DG.

Clin Cancer Res. 2016 Sep 1;22(17):4505-16. doi: 10.1158/1078-0432.CCR-15-2956. Epub 2016 Apr 8.


Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer.

Zhang D, Park D, Zhong Y, Lu Y, Rycaj K, Gong S, Chen X, Liu X, Chao HP, Whitney P, Calhoun-Davis T, Takata Y, Shen J, Iyer VR, Tang DG.

Nat Commun. 2016 Feb 29;7:10798. doi: 10.1038/ncomms10798.


Longitudinal tracking of subpopulation dynamics and molecular changes during LNCaP cell castration and identification of inhibitors that could target the PSA-/lo castration-resistant cells.

Rycaj K, Cho EJ, Liu X, Chao HP, Liu B, Li Q, Devkota AK, Zhang D, Chen X, Moore J, Dalby KN, Tang DG.

Oncotarget. 2016 Mar 22;7(12):14220-40. doi: 10.18632/oncotarget.7303.


Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties.

Paranjape AN, Soundararajan R, Werden SJ, Joseph R, Taube JH, Liu H, Rodriguez-Canales J, Sphyris N, Wistuba I, Miura N, Dhillon J, Mahajan N, Mahajan K, Chang JT, Ittmann M, Maity SN, Logothetis C, Tang DG, Mani SA.

Oncogene. 2016 Nov 17;35(46):5963-5976. doi: 10.1038/onc.2015.498. Epub 2016 Jan 25.


The total artificial heart.

Cook JA, Shah KB, Quader MA, Cooke RH, Kasirajan V, Rao KK, Smallfield MC, Tchoukina I, Tang DG.

J Thorac Dis. 2015 Dec;7(12):2172-80. doi: 10.3978/j.issn.2072-1439.2015.10.70. Review. Erratum in: J Thorac Dis. 2017 Mar;9(3):E342.


Intraoperative Use of Vascular Ultrasound to Localize Thrombus in Left Ventricular Assist Device Exchange.

Smith ES, Nelson MT, Tang DG.

Anesth Analg. 2016 Jan;122(1):27-30. doi: 10.1213/ANE.0000000000000980. No abstract available.


Cancers of the breast and prostate: a stem cell perspective.

Tang DG.

Endocr Relat Cancer. 2015 Dec;22(6):E9-E11. doi: 10.1530/ERC-15-0427. No abstract available.


Pulmonary Hypertension After Heart Transplantation in Patients Bridged with the Total Artificial Heart.

Shah R, Patel DB, Mankad AK, Rennyson SL, Tang DG, Quader MA, Smallfield MC, Kasirajan V, Shah KB.

ASAIO J. 2016 Jan-Feb;62(1):69-73. doi: 10.1097/MAT.0000000000000298.


Cell-of-Origin of Cancer versus Cancer Stem Cells: Assays and Interpretations.

Rycaj K, Tang DG.

Cancer Res. 2015 Oct 1;75(19):4003-11. doi: 10.1158/0008-5472.CAN-15-0798. Epub 2015 Aug 19. Review.


Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications.

Deng Q, Tang DG.

Endocr Relat Cancer. 2015 Dec;22(6):T209-20. doi: 10.1530/ERC-15-0217. Epub 2015 Aug 18. Review.


Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells.

Liu X, Chen X, Rycaj K, Chao HP, Deng Q, Jeter C, Liu C, Honorio S, Li H, Davis T, Suraneni M, Laffin B, Qin J, Li Q, Yang T, Whitney P, Shen J, Huang J, Tang DG.

Oncotarget. 2015 Sep 15;6(27):23959-86.


Cancer stem cells and cell size: A causal link?

Li Q, Rycaj K, Chen X, Tang DG.

Semin Cancer Biol. 2015 Dec;35:191-9. doi: 10.1016/j.semcancer.2015.07.002. Epub 2015 Aug 1. Review.


Regulation of NANOG in cancer cells.

Gong S, Li Q, Jeter CR, Fan Q, Tang DG, Liu B.

Mol Carcinog. 2015 Sep;54(9):679-87. doi: 10.1002/mc.22340. Epub 2015 May 27. Review.


Maintenance Therapy Containing Metformin and/or Zyflamend for Advanced Prostate Cancer: A Case Series.

Bilen MA, Lin SH, Tang DG, Parikh K, Lee MH, Yeung SC, Tu SM.

Case Rep Oncol Med. 2015;2015:471861. doi: 10.1155/2015/471861. Epub 2015 Mar 15.


Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions.

Jeter CR, Yang T, Wang J, Chao HP, Tang DG.

Stem Cells. 2015 Aug;33(8):2381-90. doi: 10.1002/stem.2007. Epub 2015 May 13. Review.


Surveillance Endomyocardial Biopsy in the Modern Era Produces Low Diagnostic Yield for Cardiac Allograft Rejection.

Shah KB, Flattery MP, Smallfield MC, Merinar G, Tang DG, Sheldon EH, Thacker LR, Kasirajan V, Cooke RH, Hess ML.

Transplantation. 2015 Aug;99(8):e75-80. doi: 10.1097/TP.0000000000000615.


MicroRNA-212 inhibits osteosarcoma cells proliferation and invasion by down-regulation of Sox4.

Luo XJ, Tang DG, Gao TL, Zhang YL, Wang M, Quan ZX, Chen J.

Cell Physiol Biochem. 2014;34(6):2180-8. doi: 10.1159/000369661. Epub 2014 Dec 2.


Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells.

Rycaj K, Plummer JB, Yin B, Li M, Garza J, Radvanyi L, Ramondetta LM, Lin K, Johanning GL, Tang DG, Wang-Johanning F.

Clin Cancer Res. 2015 Jan 15;21(2):471-83. doi: 10.1158/1078-0432.CCR-14-0388. Epub 2014 Nov 4.


Mechanical circulatory support devices in the ICU.

Shah KB, Smallfield MC, Tang DG, Malhotra R, Cooke RH, Kasirajan V.

Chest. 2014 Sep;146(3):848-857. doi: 10.1378/chest.13-2645. Review.


Supplemental Content

Support Center